These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. Sivonen A; Renkonen OV; Weckström P; Koskenvuo K; Raunio V; Mäkelä PH J Infect Dis; 1978 Mar; 137(3):238-44. PubMed ID: 416147 [TBL] [Abstract][Full Text] [Related]
3. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community. Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128 [TBL] [Abstract][Full Text] [Related]
4. Minocycline in the chemoprophylaxis of meningococcal disease. Guttler RB; Beaty HN Antimicrob Agents Chemother; 1972 May; 1(5):397-402. PubMed ID: 4670480 [TBL] [Abstract][Full Text] [Related]
5. Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA; 1976 Jan; 235(3):261-5. PubMed ID: 811822 [TBL] [Abstract][Full Text] [Related]
6. Antibiotics for preventing meningococcal infections. Fraser A; Gafter-Gvili A; Paul M; Leibovici L Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966 [TBL] [Abstract][Full Text] [Related]
7. Antibiotics for preventing meningococcal infections. Fraser A; Gafter-Gvili A; Paul M; Leibovici L Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease. Jackson LA; Alexander ER; DeBolt CA; Swenson PD; Boase J; McDowell MG; Reeves MW; Wenger JD Pediatr Infect Dis J; 1996 Nov; 15(11):992-8. PubMed ID: 8933547 [TBL] [Abstract][Full Text] [Related]
9. [Healthy meningococcal carriers in 1973 in Greece. Sensitivity of the isolated strains to minocycline, rifampicin and sulphadiazine (author's transl)]. Vassiliadis P; Patéraki E; Kalapothaki V; Trichopoulos D; Constantinidis E; Papadakis J Zentralbl Bakteriol Orig A; 1975; 230(2):159-71. PubMed ID: 807053 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report. Beam WE; Newberg NR; Devine LF Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195 [No Abstract] [Full Text] [Related]
11. The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population. Chapalain JC; Guibourdenche M; Perrier-Gros-Claude JD; Bartoli M; Riou JY Pathol Biol (Paris); 1992 Mar; 40(3):230-3. PubMed ID: 1608666 [TBL] [Abstract][Full Text] [Related]
12. Outbreak of group C meningococcal disease in Australian Aboriginal children. Booy R Lancet; 1995 Aug; 346(8974):572-3. PubMed ID: 7658793 [No Abstract] [Full Text] [Related]
13. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Devine LF; Pollard RB; Krumpe PE; Hoy ES; Mammen RE; Miller CH; Peckinpaugh RO Am J Epidemiol; 1973 Jun; 97(6):394-401. PubMed ID: 4197420 [No Abstract] [Full Text] [Related]
14. Antibiotics for preventing meningococcal infections. Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949 [TBL] [Abstract][Full Text] [Related]
15. Meningococcal disease in Italy. Stroffolini T; Congiu ME; Occhionero M; Mastrantonio P J Infect; 1989 Jul; 19(1):69-74. PubMed ID: 2506286 [TBL] [Abstract][Full Text] [Related]